Mergers and acquisitions (M&A) are a key enabler for businesses seeking to grow and expand in the marketplace, both existing and new ones. At the same time, global reach and increased complexity of many M&A transactions can entail unique risks, requiring careful consideration, including foreign and domestic governmental regulations on potential bribery and corruption exposures.
In addition, the markets that are foreseen in the report to see bigger deals in the current year and beyond, albeit with a pre-COVID-19 lens, are life sciences and healthcare, financial services and energy and resources. All of these, to varying degrees, entail multiple interactions with government agencies and regulators. As such, the bribery and corruption exposure is high.
Deloitte's 'The state of the deal – M&A trends 2019' report shows that the investment appetite for M&A deals is not limited to a small number of markets but rather widely spread, including a continued focus on emerging markets. However, the political and very often “complex” local business environments present key challenges for those looking to do deals in these markets.
The resultant increased scrutiny of various European governments (through for example the UK Bribery Act and the French Sapin II.) and the US (Foreign Corrupt Practices Act (FCPA)) requires businesses looking to acquire or sell a business to be aware of the specific bribery and corruption exposure as part of any broader analysis of compliance-related risks.
It is important to keep in mind that any such risks do not necessarily relate just to the jurisdiction in which the various parties of the transaction operate themselves, but that there is also potential exposure outside these borders. A common misconception is that in case a target company does not have international locations, it is not subject to regulations outside their jurisdiction. However if the target has customers or suppliers in foreign jurisdictions then additional non-domestic regulations can be triggered.
Businesses pursuing M&A opportunities are often restricted in their ability to assess in detail the Target`s bribery and corruption risk and exposure, in particular during the pre-deal due diligence phase. What is important though, even in these circumstances, is the expressed position of certain authorities (e.g. The US Department of Justice (“DOJ”), French Anti-Corruption Authority, etc.) that to not do anything in respect of such risks in the context of an M&A opportunity is not considered acceptable and may result in regulatory sanctions.
A recent matter highlights this very issue: in September 2019, the US Securities and Exchange Commission (“SEC”) announced that a UK based global oil and gas services company (formed through a merger in 2017) agreed to settle FCPA charges and pay USD 5.1 million in addition to improving its compliance procedures. The SEC alleged that the predecessor of the newly created company after the merger made over USD 794,000 in payments to a third party consultant based in Monaco, which used at least some of those funds to pay bribes to Iraqi government officials to procure business with Iraq state-owned oil companies.
It is therefore key that businesses are aware and respond to the fact that both domestic and non-domestic anti-bribery and corruption laws might be applicable to a certain M&A situation and that the potential compliance related risks are properly evaluated.
Deloitte has established a global network of specialists who can support you in addressing anti-bribery and corruption challenges at every stage of an M&A transaction. In addition to our local specialists with long-standing experience covering a wide range of industries, we deploy our advanced analytics and technological capabilities to such situations in order for our clients to get maximum insight at every step of the process. Where an exposure is identified, our specialists will stay on board and assist in developing and executing mitigating actions.